Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
The Clorox Company (CLX) is a leading household & personal products business based in the US. It opened the day at $168.52 after a previous close of $168.93. During the day the price has varied from a low of $168.00 to a high of $170.13. The latest price was $169.68 (25 minute delay). The Clorox Company is listed on the NYSE and employs 9,000 staff. All prices are listed in US Dollars.
|52-week range||$161.66 - $228.32|
|50-day moving average||$167.36|
|200-day moving average||$179.30|
|Wall St. target price||$161.66|
|Dividend yield||$4.49 (2.76%)|
|Earnings per share (TTM)||$5.58|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-09-17)||2.16%|
|1 month (2021-08-25)||2.94%|
|3 months (2021-06-25)||-3.95%|
|6 months (2021-03-25)||-11.06%|
|1 year (2020-09-25)||-19.78%|
|2 years (2019-09-25)||12.54%|
|3 years (2018-09-25)||13.39%|
|5 years (2016-09-23)||34.10%|
Valuing The Clorox Company stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of The Clorox Company's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
The Clorox Company's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 29x. In other words, The Clorox Company shares trade at around 29x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
The Clorox Company's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 6.0694. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into The Clorox Company's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
The Clorox Company's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.4 billion.
The EBITDA is a measure of a The Clorox Company's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$7.3 billion|
|Operating margin TTM||16.59%|
|Gross profit TTM||$3.2 billion|
|Return on assets TTM||12.13%|
|Return on equity TTM||95.87%|
|Market capitalisation||$20.1 billion|
TTM: trailing 12 months
There are currently 7.1 million The Clorox Company shares held short by investors – that's known as The Clorox Company's "short interest". This figure is 7.8% up from 6.6 million last month.
There are a few different ways that this level of interest in shorting The Clorox Company shares can be evaluated.
The Clorox Company's "short interest ratio" (SIR) is the quantity of The Clorox Company shares currently shorted divided by the average quantity of The Clorox Company shares traded daily (recently around 1.7 million). The Clorox Company's SIR currently stands at 4.17. In other words for every 100,000 The Clorox Company shares traded daily on the market, roughly 4170 shares are currently held short.
However The Clorox Company's short interest can also be evaluated against the total number of The Clorox Company shares, or, against the total number of tradable The Clorox Company shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case The Clorox Company's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 The Clorox Company shares in existence, roughly 60 shares are currently held short) or 0.0579% of the tradable shares (for every 100,000 tradable The Clorox Company shares, roughly 58 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against The Clorox Company.
Find out more about how you can short The Clorox Company stock.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like The Clorox Company.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 22.03
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and The Clorox Company's overall score of 22.03 (as at 12/31/2018) is pretty good – landing it in it in the 32nd percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like The Clorox Company is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 8.21/100
Social score: 7.02/100
Governance score: 2.8/100
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. The Clorox Company scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that The Clorox Company has, for the most part, managed to keep its nose clean.
|Total ESG score||22.03|
|Total ESG percentile||31.64|
|Level of controversy||2|
Dividend payout ratio: 57.42% of net profits
Recently The Clorox Company has paid out, on average, around 57.42% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.86% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), The Clorox Company shareholders could enjoy a 2.86% return on their shares, in the form of dividend payments. In The Clorox Company's case, that would currently equate to about $4.49 per share.
The Clorox Company's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
The Clorox Company's most recent dividend payout was on 12 August 2021. The latest dividend was paid out to all shareholders who bought their shares by 25 October 2021 (the "ex-dividend date").
The Clorox Company's shares were split on a 2:1 basis on 23 August 1999. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your The Clorox Company shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for The Clorox Company shares which in turn could have impacted The Clorox Company's share price.
Over the last 12 months, The Clorox Company's shares have ranged in value from as little as $161.66 up to $228.3236. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while The Clorox Company's is 0.1867. This would suggest that The Clorox Company's shares are less volatile than average (for this exchange).
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brand names; professional cleaning and disinfecting products under the CloroxPro, Clorox Healthcare, and Clorox Total 360 brand names; professional food service products under the Hidden Valley brand name; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brand names in the United States. The Household segment provides cat litter products under the Fresh Step, Scoop Away, and Ever Clean brand names; bags and wraps under the Glad brand name; and grilling products under the Kingsford and Kingsford Match Light brand names in the United States. The Lifestyle segment offers dressings, dips, seasonings, and sauces primarily under the Hidden Valley brand name; natural personal care products under the Burt's Bees brand name; and water-filtration systems and filters under the Brita brand name in the United States. The International segment provides laundry additives; home care products; water-filtration systems and filters; digestive health products; grilling products; cat litter products; food products; bags and wraps; natural personal care products; and professional cleaning and disinfecting products internationally primarily under the Clorox, Ayudin, Clorinda, Poett, Pine-Sol, Glad, Brita, RenewLife, Ever Clean and Burt's Bees brand names. The Clorox Company sells its products primarily through mass retailers, grocery outlets, warehouse clubs, dollar stores, home hardware centers, third-party and owned e-commerce channels, military stores, and distributors, as well as a direct sales force.
Everything we know about the Enfusion IPO, plus information on how to buy in.
Everything we know about the Intuity Medical IPO, plus information on how to buy in.
Everything we know about the Pyxis Oncology IPO, plus information on how to buy in.
Everything we know about the AEON Biopharma IPO, plus information on how to buy in.
Everything we know about the IHS Holding Ltd IPO, plus information on how to buy in.
Everything we know about the BT Brands IPO, plus information on how to buy in.
Everything we know about the Immix IPO, plus information on how to buy in.
Everything we know about the Keter Group SA IPO, plus information on how to buy in.
Everything we know about the Theseus Pharmaceuticals IPO, plus information on how to buy in.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq on Sep. 20, 2021
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.